Discriminant Analysis Results Using Only SUV of Metastases as Independent Variable for Prediction of 2 Groups Defined by 364-Day Survival
| MS | CCR survival < 364 d | CCR survival ≥ 364 d | CCR (both groups) |
|---|---|---|---|
| First | 58.33% (14/24) | 78.95% (15/19) | 67.44% (29/43) |
| Second | 52.38% (11/21) | 75.00% (12/16) | 62.16% (23/37) |
| Third | 57.14% (12/21) | 86.66% (13/15) | 69.44% (25/36) |
| First plus second | 57.14% (12/21) | 73.33% (11/15) | 63.89% (23/36) |
| Second plus third | 60.00% (12/20) | 73.33% (11/15) | 65.71% (23/35) |
| First plus third | 57.14% (12/21) | 86.67% (13/15) | 69.44% (25/36) |